Nadiuska Terrero thought her biggest medical hurdle was behind her after a kidney transplant in 2010. A decade later, in the midst of the COVID19 pandemic, she again found herself facing an uphill challenge – stage I colon cancer.
In the election week that has yet to end, we take a break from our regular weekly roundup. You don’t need more articles to read today, but maybe, just maybe, you could use some momentary distraction. We’ve got you covered in one quick stop.
At the end of October, the U.S. Preventive Services Task Force updated their colon cancer screening guidelines to lower the age at which people should begin screening from age 50 to 45—a critical change that reflects a climbing trend of higher rates of colon and rectal cancer in younger people.
This is a series about what we know and what we don’t know. Paul Kurlansky, MD, associate director of the Center for Innovation and Outcomes Research at Columbia, tackles the important topics thoughtfully and without conjecture. He’s here to illuminate new research in a clear and concise (and distinctly Dr. Kurlansky) way.